Advances in oral treatment of inflammatory bowel disease using protein-based nanoparticle drug delivery systems

Advances in oral treatment of inflammatory bowel disease using protein-based nanoparticle drug delivery systems

Inflammatory bowel disease (IBD) comprises chronic autoimmune disorders with significant morbidity, highlighting the need for advanced, noninvasive, targeted therapies. Protein-based nanoparticle drug delivery systems (PNP-DDSs) have emerged as promising platforms to overcome limitations of conventi...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhihao Lin, Ziheng Zhao, Xianrui Lin, Zhenlin Yang, Lin Wang, Rui Xi, Dingpei Long
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Drug Delivery
Subjects:
Inflammatory bowel disease
nanomedicine
protein-based nanoparticles
oral drug delivery
active targeting
stimuli-responsive delivery
Online Access:https://www.tandfonline.com/doi/10.1080/10717544.2025.2544689
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/10717544.2025.2544689

Similar Items